Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B.

Author: CabreusPhilip, RystedtAlma, SwartlingCarl

Paper Details 
Original Abstract of the Article :
Hyperhidrosis can seriously impair patients' quality of life. Medical history, including heredity and hyperhidrosis during youth, as well as current age and time elapsed since menopause, is important to consider when distinguishing between postmenopausal hyperhidrosis and vasomotor symptoms to enabl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/1346-8138.15029

データ提供:米国国立医学図書館(NLM)

Botulinum Toxin Type B for Postmenopausal Craniofacial Hyperhidrosis

Hyperhidrosis, excessive sweating, can be a distressing condition. This study focused on [postmenopausal craniofacial hyperhidrosis], a specific type of hyperhidrosis that can be challenging to treat. They investigated the effectiveness of [botulinum toxin type B (Btx type B)] as a treatment option. They enrolled eight postmenopausal women and randomly assigned them to receive either Btx type B or placebo.

Btx Type B Shows Promise for Postmenopausal Hyperhidrosis

The preliminary results suggest that Btx type B might be a safe and effective treatment for postmenopausal craniofacial hyperhidrosis. The study found that Btx type B led to a significant improvement in the Dermatology Life Quality Index (DLQI) score, indicating an improvement in quality of life. It’s like finding a refreshing oasis in the desert, providing relief from the discomfort and social anxiety associated with hyperhidrosis.

Living with Postmenopausal Hyperhidrosis

Postmenopausal hyperhidrosis can be a challenging condition, but this research offers a potential treatment option. While further research is needed, the study provides a glimmer of hope for women seeking relief from this condition. It’s important to talk to a healthcare professional to discuss treatment options and find the best approach for your individual needs.

Dr. Camel's Conclusion

This research explores a potential treatment for postmenopausal craniofacial hyperhidrosis. The findings suggest that Btx type B might be an effective and safe option for improving quality of life. It’s a reminder that there are possibilities for managing even the most challenging conditions.

Date :
  1. Date Completed 2019-11-13
  2. Date Revised 2020-01-08
Further Info :

Pubmed ID

31373068

DOI: Digital Object Identifier

10.1111/1346-8138.15029

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.